Profile for European Patent Office Patent: 2701720
✉ Email this page to a colleague
| Country | SPC | SPC Expiration |
|---|---|---|
| Netherlands | 301206 | ⤷ Start Trial |
| Denmark | CA 2022 00054 | ⤷ Start Trial |
| Lithuania | PA2022529 | ⤷ Start Trial |
| Belgium | 2023C/504 | ⤷ Start Trial |
US Patent Family Members and Approved Drugs for European Patent Office Patent: 2701720
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
